For the Inventor, By the Inventor

Enter assignee name

Stamford, CT, United States of America

Cara Therapeutics, Inc.

USPTO Granted Patents = 31

CIPO Patents = 2

EPO Patents = 4

Trademarks = 3

Forward Citations = 571

Loading Chart...

Loading Chart...

28 inventors (with patents filed for the assignee):

Claudio Daniel Schteingart (17 out of 27 patents)

Frédérique Menzaghi (16 out of 19 patents)

Guangcheng Jiang (16 out of 26 patents)

4. Roberta Vezza Alexander (16 out of 17 patents)

5. Javier Sueiras-Diaz (16 out of 19 patents)

6. Derek T Chalmers (16 out of 37 patents)

7. Robert H Spencer (15 out of 17 patents)

8. Zhiyong Luo (13 out of 13 patents)

9. Robert Zhiyong Luo (10 out of 15 patents)

10. Gary Gustafson (6 out of 44 patents)

11. Stephen J O'Connor (5 out of 26 patents)

12. R Paul Beckett (4 out of 4 patents)

13. Carla M Gauss (4 out of 4 patents)

14. Janet L Ralbovsky (4 out of 9 patents)

15. Tatiana Shelekhin (3 out of 23 patents)

31 patents: Sort by Forward Citations

1. 11986509 - Oligosaccharide formulations of kappa opioid receptor agonists (2024-05-21),

2. 11684674 - Oral formulations of kappa opioid receptor agonists (2023-06-27),

3. 11033629 - Oral formulations of kappa opioid receptor agonists (2021-06-15),

4. 10913769 - Synthetic peptide amides and dimers thereof (2021-02-09),

5. 10793596 - Synthetic peptide amides (2020-10-06),

6. 10138270 - Synthetic peptide amides (2018-11-27),

7. 10017536 - Synthetic peptide amides and dimers thereof (2018-07-10),

8. 9359399 - Synthetic peptide amides (2016-06-07),

9. 9334305 - Synthetic peptide amides and dimers thereof (2016-05-10),

10. 9321810 - Uses of kappa opioid synthetic peptide amides (2016-04-26),

11. 8951970 - Synthetic peptide amides for pain (2015-02-10),

12. 8859538 - Uses of substituted imidazoheterocycles (2014-10-14),

13. 8835422 - Substituted imidazoheterocycle derivatives (2014-09-16),

14. 8669079 - [object Object] (2014-03-11),

15. 8653127 - Bicyclic pyrazolo-heterocycles (2014-02-18),

Cara Therapeutics, Inc. is a biopharmaceutical company that develops innovative drug candidates to treat various diseases and disorders. Headquartered in Stamford, Connecticut, the company focuses on developing and commercializing novel therapies to alleviate pain and pruritus by targeting kappa opioid receptors. Cara's pipeline includes multiple clinical-stage product candidates with the potential to improve the lives of patients. For more information, visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

31 Patents

#26 in Stamford, CT

#255 in Connecticut

#10,562 in US

#20,639 in the World

Stamford, CT, United States of America

Cara Therapeutics, Inc.

Forward Citations = 571

28 inventors:

Claudio Daniel Schteingart (17 out of 27 patents)

Frédérique Menzaghi (16 out of 19 patents)

Guangcheng Jiang (16 out of 26 patents)

4. Roberta Vezza Alexander (16 out of 17 patents)

5. Javier Sueiras-Diaz (16 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…